REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.